Legend Biotech Corp (LEGN)
40.03
+0.02
(+0.05%)
USD |
NASDAQ |
Jun 03, 16:00
41.00
+0.97
(+2.42%)
After-Hours: 07:04
Legend Biotech Accounts Payable (Quarterly): 39.48M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 39.48M |
December 31, 2023 | 19.56M |
September 30, 2023 | 17.17M |
June 30, 2023 | 21.54M |
March 31, 2023 | 29.81M |
December 31, 2022 | 31.69M |
June 30, 2022 | 12.24M |
March 31, 2022 | 9.712M |
Date | Value |
---|---|
December 31, 2021 | 7.043M |
September 30, 2021 | 11.59M |
March 31, 2021 | 9.649M |
December 31, 2020 | 4.911M |
September 30, 2020 | 7.399M |
June 30, 2020 | 6.976M |
March 31, 2020 | 10.12M |
December 31, 2019 | 9.586M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.911M
Minimum
Dec 2020
39.48M
Maximum
Mar 2024
15.53M
Average
10.86M
Median
Accounts Payable (Quarterly) Benchmarks
Johnson & Johnson | 8.174B |
Bristol-Myers Squibb Co | 3.539B |
2seventy bio Inc | 8.801M |
Exelixis Inc | 26.07M |
Fortrea Holdings Inc | 131.30M |